2. TOPIC MODULES
1. Blood and its products
a. Whole blood
b. Platelets
c. Red cell preparation
d. Fresh frozen plasma
e. Cryoprecipitates
f. Plasma products
2. Transfusion reactions
• Acute and chronic
3. TRANSFUSION OF FRESH BLOOD
FOR ACUTE BLOOD LOSS – WHOLE BLOOD
FOR BLEEDING DISORDERS – PRBC, FFP AND OTHER
BLOOD COMPONENTS DEPENDING ON NATURE OF
DEFICIENCY
4. WHOLE BLOOD
HAEMATOCRIT 35 –45%
450ml each unit
STORAGE 2 – 60C MAX 35 DAYS
CHANGES IN STORED BLOOD
HYPERKALEMIA
LOW WBCs
THROMBOCYTOPENIA
LOW LEVEL OF LABILE CLOTTING FACTORS
INCREASED LACTATE LEVEL
ACIDOTIC
5. RED CELL PREPARATIONS
RED CELL HAEMATOCRIT 65-75%
330ml each unit
STORAGE 2–6 0C MAX 35 DAYS
INDICATIONS
TO INCREASE TISSUE OXYGENATION AFTER
HEMORRHAGE
CHRONIC ANEMIA
ELDERLY AND CHILDREN
CARDIAC PATIENTS
SAME PRECAUTIONS AS WHOLE BLOOD
6. PLATELETS
EACH UNIT 55000 Platlets/uL
SHELF LIFE 5 DAYS
HLA COMPATIBLE OR CROSSMATCHED AND SHOWN TO
BE COMPATIBLE WITH PATIENT SERUM
INDICATIONS
THROMBOCYTOPENIA
FUNCTIONAL DEFORMITY OF PLATELETS--
(GLANZMAN DISEASE)
BEFORE SURGERY IF PLATELETS COUNT IS BELOW
50,000 cumm
ACUTE DIC (ALONG WITH FFP)
7. FRESH FROZEN PLASMA
PLASMA FROM FRESH BLOOD IS RAPIDLY FROZEN.
EACH UNIT = 200 – 300 ml PLASMA
PLASMA PROTEIN IN SIMILAR CONCENTRATION AS
NORMAL PLASMA
STORED AT -400C ,SHELF LIFE 24 MONTHS
THAWED RAPIDLY AT 370C IMMEDIATELY BEFORE USE
BLOOD GROUP MUST BE COMPATIBLE
TRANSFUSION SHOULD BE COMPLETED WITHIN 4
HOURS
8. INDICATIONS:
TO CORRECT ISOLATED PLASMA PROTEIN
DEFICIENCIES, FACTORS II,V,VII,VIII, IX, X, XIII,
ANTITHROMBIN III.
TO REVERSE ORAL ANTICOAGULATION WITH
WARFARIN
LIVER DISEASE, MAJOR HEPATIC RESECTION, SEVERE
INJURIES--
DIC (ALONG WITH PLATELETS)
9. CRYOPRECIPITATES
CONCENTRATE OF FACTOR VIII, VON WILLIBRAND
FACTOR AND FIBRINOGEN
1 UNIT 20 ml
STORAGE = - 300C , MAX. 24 MONTHS
THAWED RAPIDLY BEFORE USE COMPLETED WITHIN
4 HOURS
11. PLASMA PRODUCTS
i) COAGULATION FACTORS
ii) FACTOR VIII CONCENTRATE (HEMOPHILIA A)
iii) FACTOR IX CONCENTRATE (CHRISTMAS DIS.)
iv) HEPATITIS B IMMUNOGLOBULIN
v) TETANUS IMMUNOGLOBULIN-
vi) HUMAN ANTI D IMMUNOGLOBULIN-
vii) HUMAN RABIES IMMUNOGLOBULIN-
DO NOT REQUIRE ABO COMPATIBILITY
SHELF LIFE 24-36 MONTHS
12. INDICATIONS OF BLOOD COMPONENT THERAPY
Packed RBCs:
a hemoglobin of 7 to 8 g/dL,
a markedly decreased oxygen saturation and/or orthostatic
hypotension.
Platelets:
Indicated for a
platelet count of less than 50,000/microliter.
there is active bleeding,
if a procedure such as surgery is to be performed.
Spontaneous bleeding is unlikely until the platelet count
drops below 10,000 to 20,000/microliter.
13. • FFP:
In a patient has multiple factor deficiencies and is bleeding.
Thrombotic thrombocytopenic purpura (TTP).
The PT and PTT will be prolonged, and the INR generally should be
greater than 1.6.
• Cryoprcipitate:
Haemophilia
Hypofibrinogenemia,
vonWillebrand disease,
in situations calling for a "fibrin glue."
17. INVESTIGATION OF ACUTE HEMOLYTIC
TRANSFUSION
1) REPORT TO BLOOD TRANSFUSION DEPARTMENT
2) ESTABLISH THAT THE UNIT ISSUED TO THE PROPER
PATIENT
3) OBTAIN FRESH SAMPLES
4) SEND SAMPLE OF BLOOD UNIT FOR CULTURE
5) RETURN BLOOD TO BLOOD BANK
6) BLOOD FOR Hb %, UREA, S/ELECTROLYTES
18. ALLERGIC REACTIONS
• WITHIN MINUTES
TREATMENT
• ANTIHISTAMINES
• REDUCE TRANSFUSION RATE
S/S
• RASH, ITCHING, laryngeal aedma leading to SOB
19. NON HEMOLYTIC FEBRILE REACTIONS
• CAUSE =GRAFT VS HOST RESPONSE FROM
LEUCOCYTE ANTIGEN=
S/S
• RIGORS,FEVER WITHIN 30 MINUTES
TREATMENT
• SLOW/STOP TRANSFUSION
• ANTIPYRETICS
• PROPHYLACTIC ANTIPYRETICS BEFORE NEXT
TRANSFUSIONS
20. ANAPHYLACTIC REACTIONS;
• RARE 1/ 20000
CAUSE
• IgA ANTIBODIES
• LOW SERUM IgA
S/S
• HYPOTENSION
• LARYNGEAL OEDEMA
• CUTANEOUS FLUSHING
• BRONCHOSPASM
22. TRANSFUSION RELATED ACUTE LUNG INJURY
(TRALI)
CAUSE
• ANTIBODIES TO LEUKOCYTES IN DONOR BLOOD
S/S
• FEVER,COUGH
• BREATHLESSNESS,HYPOXEMIA
23. TREATMENT;
• GOOD INTENSIVE CARE
• CARDIAC AND PULMONARY SUPPORT
• ANTIBIOTICS
• MAY NEED VENTILATORY SUPPORT
• DEATH DUE TO
MULTI ORGAN FAILURE
INFECTION
24. Solution (Specialized products)
• Washed RBC’s: A unit of packed red blood cells (PRBCs) is
washed to reduce plasma proteins. This reduces the risk for
allergic transfusion reactions. Washing reduces
immunoglobulins, such as anti-IgA that could cause
anaphylactic transfusion reactions in persons with selective
IgA deficiency.
• Leucocyte reduction: Red blood cell and platelet units may be
filtered to remove most of the leukocytes (white blood cells).
This may reduce the risk for febrile transfusion reactions, may
help prevent alloimmunizaton to MHC (HLA) donor antigens, and
help reduce the risk for cytomegalovirus (CMV) infection.
25. Irradiated Blood
• Irradiation is needed to destroy all living
leukocytes (white blood cells), particularly
lymphocytes that could cause transfusion
associated graft versus host disease (TAGVD).
26. SEPTIC SHOCK :
• DISASTROUS COMPLICATION.
• DIFFICULT TO DIFFERETIATE FROM ACUTE
HEMOLYTIC TRANSFUSION REACTION.
• MAJORITY DO NOT SURVIVE
PATHOGENS
• PSEUDOMONAS
• YERSINIA
• STAPHYLOCOCCI
28. CIRCULATORY OVERLOAD
• RAPID OR LARGE VOLUMES
SEVERE , CHRONIC ANEMIAS
PRECAUTIONS
• VERY SLOW TRANSFUSION.
• PACKED CELLS
• DIURETICS
COMPLICATION
• PULMONARY OEDEMA
29. LATE REACTIONS
DELAYED HEMOLYTIC TRANSFUSION REACTIONS
LOW LEVEL OF ANTIBODIES TO BLOOD GROUP
ANTIGEN
5 TO 10 DAYS LATE DESTRUCTION OF
TRANSFUSED CELLS
FEVER, FALLING Hb, JAUNDICE, HbURIA
31. HEMOLYTIC DISEASE OF NEW BORN
Rh INCOMPATIBLE TRANSFUSION
IMMUNE SUPPRESSION
WOUND COMPLICATIONS IN PERIOPERATIVE
TRANSFUSIONS
32. TRANSFUSION IRON OVERLOAD
(HEMOSIDEROSIS)
1 UNIT…. 250mg OF IRON
REPEATED TRANSFUSIONS OVER YEARS
REFRACTIVE ANEMIAS
THALASSEMIAS
LIVER,PANCREAS,MYOCARDIUM
TREATMENT IS DESFERRIOXAMINE.